China Universal Asset Management »

Kyverna Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $46k 7.6k 6.00
2025-06-30 $27k 8.7k 3.07
2025-03-31 $17k 8.7k 1.93
2024-12-31 $34k 9.2k 3.74

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Vanguard Group
Insight Holdings
Franklin Resources
Mbb Public Markets I
Catalio Capital Management
Millennium Management
BlackRock
Kera Capital Partners
Peapod Lane Capital
Geode Capital Management
Woodline Partners
Susquehanna International

View all funds holding Kyverna Therapeutics